|
23 Jan 2007 |
Coley Pharmaceutical Group Updates Hepatitis C Drug Development Strategy
|
|
19 Jan 2007 |
Targeted Genetics Announces Publication of Inflammatory Arthritis Study in Molecular Therapy
|
|
18 Jan 2007 |
Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
|
|
18 Jan 2007 |
Studies Show Geron's Stem Cell Therapeutic For Spinal Cord Injury Produces Nerve Growth Factors
|
|
18 Jan 2007 |
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
|
|
17 Jan 2007 |
Gentium Receives Orphan Drug Designation from FDA for Defibrotide to Prevent Hepatic Veno-occlusive Disease
|
|
16 Jan 2007 |
Osiris Therapeutics Receives European Orphan Drug Designation for PROCHYMAL
|
|
13 Jan 2007 |
ReNeuron provides a further update on the IND application for ReN001
|
|
12 Jan 2007 |
Ark Holds Positive End of Phase II Meeting with FDA on Trinam(R) Gene Therapy
|
|
12 Jan 2007 |
Genvec Receives Clearance From FDA For Eus Administration Of TNFerade
|
|
12 Jan 2007 |
Takara Bio Obtains Clinical Trial Approval of Gene Therapy Treatment for Chronic Granulomatosis
|
|
10 Jan 2007 |
Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics
|
|
10 Jan 2007 |
Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
|
|
10 Jan 2007 |
Mirus Bio Corporation Enters Into Agreement with Pfizer Inc to Evaluate RNAi Delivery Technology
|
|
09 Jan 2007 |
Osiris Therapeutics Receives FDA Fast Track Status for Its Crohn’s Disease Stem Cell Therapy and Clearance to Start Phase III Clinical Trial
|
|
09 Jan 2007 |
ProNAi Announces Dna Interference (DNAI(R)) Drug Development Strategy For 2007
|
|
06 Jan 2007 |
Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ
|
|
04 Jan 2007 |
Archemix Announces Initiation of Phase I Clinical Trial for Novel, Selective Anti-Platelet Aptamer (ARC1779)
|
|
03 Jan 2007 |
Amorcyte Cardiac Cell Therapy Trial Passes First Stage and Opens Two New Sites
|
